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Introduction 
Doxapram is a respiratory stimulant thought to act by stimulating 
medullary neurones and carotid oxygen receptors (Kato and Buckley 
1964). It changes neither oxygen uptake nor CO2 production, 
but produces substantial hyperventilation (Calvedey et al 1983). 
Hyperventilation occurs during naturally occurring or phar- 
macologically induced panic attacks, and perhaps also in panic 
patients between attacks (Gorman et al 1984, 1986). In panic 
disorder, central respiratory centers (Woods et al 1988) or a 
"suffocation alarm" center (Klein in press) may be hyperexcit- 
able. We report here a pilot study designed to test the possibility 
that in panic diserder these centers may be hypersensitive to 
doxapram. 
Subjects and Methods 
Subjects of the study were (1) five patients (4 women, 1 man, 
mean age 32 years, range-19-47) with DSM-III-R panic disorder 
with or without agoraphobia; (2) five normal controls (all women, 
mean age 34 years, range-28-39); and (3) three male psychiatrists 
(age 63, 36, and 34) who were investigators in the study. Status 
of patients and controls was determined by structured interview, 
medical and psychiatric history, arid physical examination. Sub- 
jects were excluded for heavy use of caffeine, tobacco, alcohol, 
or other substance abuse or any significant medical condition. 
All were medication free for at least I month. Subjects were 
informed that they would receive a placebo and a doxapram 
injection, without knowing when they were to occur. They were 
told that doxapram would cause hyperventilation, tachycardia, 
and a hot sensation in the head and trunk, lasting about 5 rain. 
Written consent was obtained. Noninvestigator subjects were 
paid $50. 
On the scheduled day, patients skipped lunch and at about 2 
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eM were placed in a comfortable reclining chair. A butterfly 
needle was placed in a dorsal hand vein and connected to a slow, 
normal saline drip. Electrocardiographic leads were connected 
for continuous recording. A nose clip was applied, and the subject 
breathed through a soft plastic mouthpiece connected to a 
CAD*NET SYSTEM 2001 (Medical Graphics Corp., St. Paul, 
MN) permitting breath-by-breath analysis of ventilation and gas 
exchange. Three consecutive monitoring periods of approxi- 
mately 5-15 rain were carried out. Nothing was ad~iis tered 
during the first period, which served for measuring and extin- 
guishing responses to the novel situation. During the second 
period, a saline injection was administered through the intra- 
venous tubing, and during the htfird, doxapra,'n r, ~ _ , a ,~  . . . . . .  rv,,s body 
weight was administered over 15 sec by the same route. Injections 
were given single blind. The psychiatrist-subjects did not undergo 
adaptation or placebo periods. 
Prior to the adaptation period, subjects were interviewed about 
their subjective state at that moment, including moods, feelings, 
thoughts, bodily sensations, and ratings of intensity of global 
distress and individual panic symptoms. After baseline stabili- 
zation of physiological measures following each injection, sub- 
jects were again interviewed and gave similar ratings about the 
preceding period. A panic attack was scored if: (a) the subject 
called the experience a panic attack; and (b) rated four or more 
DSM-III-R panic attack symptoms as at least "moderate" on a 
4-point scale of "not at all," "mild," "moderate," and "'severe" 
and (c) rated the experience as 5 or more on a 7-point scale 
where l was "no similarity" and 7 was "identical" to a naturally 
occurring panic attack. Criterion (c) was omitted for nonpatient 
subjects. Subjects also gave 0 to !c~ an r.logue ratings for sub- 
jective units of distress (SUD) at each interview. 
Physiologic measures were averaged over consecutive l-min 
epochs. Patients and controls were compared at each time point 
by unpaired t-tests. One-tailed tests of significance at p < 0.05 
were employed. 
Results 
Following doxapram, every subject described a hot sensation, 
usually beginning in the perineum, then radiating over the trunk 
and head. Self-ratings of distress and total severity ratings of panic 
attack symptoms were higher in patients than in controls at all time 
points, significantly so during the adaptation and doxapram pe- 
riods. No subject met panic attack criteria during the adaptation or 
placebo periods. Following doxapram, four of five patients, one 
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of five controls, and none of the three psychiatrist-subjects met the 
s~cified criteria for a panic attack (p < 0.03 excluding the psy- 
chiatrists, p < 0.01 including them). Heart rate was similar in pa- 
tients and controls during adaptation and placebo periods and in- 
creased markedly following doxaprai, with nonsignificant trends 
toward greater increase in patients. Respiratory rate, tidal volume, 
and minute ventilation increased markedly in both groups follow- 
ink doxapram. The following were significantly greater in patients 
postdoxapram: respiratory rate at 4 min; tidal volume at 5 and 8 
min; minute ventilation at 4 and 5 min. As shown in Figure 1, end 
tidal pCO: was lower in patients than in controls at all time points, 
the differences being significant during adaptation and at min 3 
through 9 postdoxapram. 
Discussion 
Aside from the known effects of doxapram, the most robust 
findings were the greater anxiogenic (including panicogenic) ef- 
feet in patients and the larger ventilatory response, manifested 
most robustly by respiratory alkalosis. The greater ventilatory 
response could be either a cause or a result of the greater anx- 
iogenic effects. As with other panicogenic probes, these could 
be caused by either group differences in biological sensitivity to 
the drug or to cognitively mediated differences in fear of the 
somatic sensations caused by the drug. The biological possibil- 
ities are numerous, but include group differences in metabolism 
of doxapram and differential sensitivities of respiratory control 
or "suffocation alarm" systems as outlined earlier. In a small 
pilot study such as this, a number of issues remain unaddressed. 
The possibility that the findings were caused by chance variation 
and small sample size must be considered. Whether doxapram 
might trigger panic attacks in other disorders has not been ex- 
plored, nor is it known whether repeat challenge in patients with 
paaic disorder would prodtt~ ~i,,,,b,, results. Additional research 
is necessary in order to resolve these issues. The results to date 
suggest that doxapram may be an additional useful probe for 
investigating the pathophysiology of panic disorder. 
40 - * 
39  " T T t "1" 
38 
37 
3 5  . 
3 4  
>, 
im 













I ' I I ' I 
1 6 0 3 
Adaptat ion Placebo 
t 
I J 
1 - t a l l  
* p < . 0 3  
** p < . 0 2  
*** p <.01 
**** p < .003 
IA 
t 
¢t  I t  , * 
t t  
~t t t • 
~ ~,~ T 
t 
/ T 
N = S  
I ' I ' I ' I ' I ' I ' I ' ' I ~ I ' I ' 
- 3  - 2  -1 0 1 2 3 4 5 6 7 8 9 
Doxapram 
Figure 1. Response of panic patients and control subjects to laboratory adaptation, placebo administration, and doxapram. 
End tidal pCO2, +_ SEM. 
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